Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis

Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis

We present the long-term outcomes of 44 patients who developed cerebral venous sinus thrombosis after vaccination with the adenoviral vector ChAdOx1 nCoV-19 COVID-19 vaccine. Assessment of the Extended Glasgow Outcome Scale was performed within 3–6 months after the initial hospital admissions. Patie...

Full description

Bibliographic Details
Main Authors: Berg, P. (Author), Fiedler, S.A (Author), Funk, M.B (Author), Henkes, H.H (Author), Kehr, S. (Author), Keller-Stanislawski, B. (Author), Meyer, B. (Author), Müller, S. (Author), Oberle, D. (Author), Ruppert-Seipp, G. (Author), Witzenhausen, C. (Author), Wolf, M.E (Author)
Format: Article
Language:English
Published: Nature Research 2022
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items